Menin inhibition with revumenib for <i>NPM1</i> -mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study

Martha L. Arellano, Michael J. Thirman, John F. DiPersio, Maël Heiblig, Eytan M. Stein, Andre C. Schuh, Andrius Žučenka, Stephane de Botton, Carolyn S. Grove, Gabriel N. Mannis, Cristina Papayannidis, Alexander E. Perl, Ghayas C. Issa, Ibrahim Aldoss, Ashish Bajel, David S. Dickens, Michael W. M. Kühn, Ioannis Mantzaris, Emmanuel Raffoux, Elie Traer, Irina Amitai, Hartmut Döhner, Corinna Greco, Tibor Kovacsovics, Christine M. McMahon, Pau Montesinos, Arnaud Pigneux, Paul J. Shami, Richard M. Stone, Ofir Wolach, John G. Harpel, Yakov Chudnovsky, Li Yu, Rebecca G. Bagley, Angela R. Smith, James S. Blachly

Open source

DOI
10.1182/blood.2025028357
Published
2025-08-28
Container
Blood
Publisher
American Society of Hematology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/blood.2025028357,
  title = {Menin inhibition with revumenib for
                    <i>NPM1</i>
                    -mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study},
  author = {Martha L. Arellano and Michael J. Thirman and John F. DiPersio and Maël Heiblig and Eytan M. Stein and Andre C. Schuh and Andrius Žučenka and Stephane de Botton and Carolyn S. Grove and Gabriel N. Mannis and Cristina Papayannidis and Alexander E. Perl and Ghayas C. Issa and Ibrahim Aldoss and Ashish Bajel and David S. Dickens and Michael W. M. Kühn and Ioannis Mantzaris and Emmanuel Raffoux and Elie Traer and Irina Amitai and Hartmut Döhner and Corinna Greco and Tibor Kovacsovics and Christine M. McMahon and Pau Montesinos and Arnaud Pigneux and Paul J. Shami and Richard M. Stone and Ofir Wolach and John G. Harpel and Yakov Chudnovsky and Li Yu and Rebecca G. Bagley and Angela R. Smith and James S. Blachly},
  year = {2025},
  journal = {Blood},
  doi = {10.1182/blood.2025028357},
  url = {https://doi.org/10.1182/blood.2025028357}
}

RIS

TY  - JOUR
TI  - Menin inhibition with revumenib for
                    <i>NPM1</i>
                    -mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study
AU  - Martha L. Arellano
AU  - Michael J. Thirman
AU  - John F. DiPersio
AU  - Maël Heiblig
AU  - Eytan M. Stein
AU  - Andre C. Schuh
AU  - Andrius Žučenka
AU  - Stephane de Botton
AU  - Carolyn S. Grove
AU  - Gabriel N. Mannis
AU  - Cristina Papayannidis
AU  - Alexander E. Perl
AU  - Ghayas C. Issa
AU  - Ibrahim Aldoss
AU  - Ashish Bajel
AU  - David S. Dickens
AU  - Michael W. M. Kühn
AU  - Ioannis Mantzaris
AU  - Emmanuel Raffoux
AU  - Elie Traer
AU  - Irina Amitai
AU  - Hartmut Döhner
AU  - Corinna Greco
AU  - Tibor Kovacsovics
AU  - Christine M. McMahon
AU  - Pau Montesinos
AU  - Arnaud Pigneux
AU  - Paul J. Shami
AU  - Richard M. Stone
AU  - Ofir Wolach
AU  - John G. Harpel
AU  - Yakov Chudnovsky
AU  - Li Yu
AU  - Rebecca G. Bagley
AU  - Angela R. Smith
AU  - James S. Blachly
PY  - 2025
JO  - Blood
DO  - 10.1182/blood.2025028357
UR  - https://doi.org/10.1182/blood.2025028357
ER  -

APA

Arellano, M. L., Thirman, M. J., DiPersio, J. F., Heiblig, M., Stein, E. M., Schuh, A. C., Žučenka, A., Botton, S. D., Grove, C. S., Mannis, G. N., Papayannidis, C., Perl, A. E., Issa, G. C., Aldoss, I., Bajel, A., Dickens, D. S., Kühn, M. W. M., Mantzaris, I., Raffoux, E., Traer, E., Amitai, I., Döhner, H., Greco, C., Kovacsovics, T., McMahon, C. M., Montesinos, P., Pigneux, A., Shami, P. J., Stone, R. M., Wolach, O., Harpel, J. G., Chudnovsky, Y., Yu, L., Bagley, R. G., Smith, A. R., & Blachly, J. S. (2025). Menin inhibition with revumenib for <i>NPM1</i> -mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study. Blood. https://doi.org/10.1182/blood.2025028357

Source records